Citius Pharmaceuticals Inc (CTXR)

[Edward]

This was released on 2/14/2024, and the BLA was filed on 2/13/2024 with the FDA.

So if CTXR is correct CTXR should receive an answer within the next 2 weeks.

As of now, the 9:16am Pre market is looking good. Just have to wait and see if the normal trading hours follow through.

"FDA acceptance of the completed resubmission package and issuance of a Prescription Drug User Fee Act (PDUFA) date is expected within 30 days of resubmission."

https://citiuspharma.com/investors/news-media/news/release-details/2024/Citius-Pharmaceuticals-Resubmits-the-Biologics-License-Application-of-LYMPHIR-Denileukin-Diftitox-for-the-Treatment-of-Adults-with-Relapsed-or-Refractory-Cutaneous-T-Cell-Lymphoma/default.aspx